← Back to Search

Unknown

BMS-963272 for Non-alcoholic Fatty Liver Disease

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 166 days

Summary

This trial is testing a new drug called BMS-963272 to see if it is safe and well-tolerated in people with severe liver disease. The study focuses on those with nonalcoholic fatty liver disease (NAFLD) and a high chance of advanced fibrosis.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 166 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 166 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of clinically significant changes in electrocardiogram (ECG) parameters: PR interval
Incidence of clinically significant changes in electrocardiogram (ECG) parameters: QRS interval
Incidence of clinically significant changes in electrocardiogram (ECG) parameters: QT interval
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Treatment (BMS-963272) Dosing Regimen 2Experimental Treatment1 Intervention
Group II: Active Treatment (BMS-963272) Dosing Regimen 1Experimental Treatment1 Intervention
Group III: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BMS-963272
2019
Completed Phase 1
~160

Find a Location

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,682 Previous Clinical Trials
4,129,560 Total Patients Enrolled
9 Trials studying Non-alcoholic Fatty Liver Disease
895 Patients Enrolled for Non-alcoholic Fatty Liver Disease
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top